HEALTHSTORY 626· JULY 1, 2026

Anthropic Enters Drug Development With Claude Science Launch; Trump Drug Pricing Plan Faces Mid-Size Pharma Test

Anthropic has released Claude Science, a version of its large language model configured specifically for scientific laboratories and pharmaceutical research operations, becoming the first large artif

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 625Avista Healthcare Partners Closes Acquisition of Sanotact Group GmbH NEXT STORY 627 →Mobility Global Inc. Launches as Independent NYSE-Listed Automotive Data Company After S&P Global Separation

Keep reading

More from the desk.

14HEALTH

FDA clears first CELMoD drug for blood cancer as a $6.7 billion shareholder lawsuit returns to court

Multiple myeloma, a blood cancer, now has a new oral treatment approved by U.S. regulators. The Food and Drug Administration cleared Zenbexus, made by Bristol Myers Squibb, as the first drug in a new class called CELMoDs and the first drug…

health2 MIN

52HEALTH

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

health2 MIN

68HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk